Armata Pharmaceuticals, Inc. (ARMP) Misses Q3 EPS by 24c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q3 EPS of ($0.74), $0.24 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $0 versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Mizuho Starts Sol Gel Technologies Ltd. (SLGL) at Outperform
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook